title: Adjunctive therapy and management of the transition of care in patients with heart failure.
abstract: Heart failure is a costly and difficult disease to treat. However, new metrics make it an imperative to keep these patients out of the hospital. Implementing and maintaining patients on successful treatment plans is difficult. A multitude of factors make transitioning care to the outpatient setting difficult. A careful and well-orchestrated team of cardiologists, general practitioners, nurses, and ancillary support staff can make an important difference to patient care. A strong body of literature supports the use of pharmacologic therapy, and evidence-based therapies can improve mortality and quality of life, and reduce hospital admissions. Adjunctive therapies can be equally important.
authors.affiliation: Division of Cardiology, Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA 19102, USA.
authors.forename: Scott
authors.initials: S
authors.lastname: Feitell
authors.forename: Shelley R
authors.initials: SR
authors.lastname: Hankins
authors.forename: Howard J
authors.initials: HJ
authors.lastname: Eisen
mesh_terms: D000223:Adaptation, Psychological; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000428:Alcohol Drinking / Q000517:prevention & control; D000553:Ambulatory Care / Q000379:methods; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D058406:Cardiac Resynchronization Therapy / Q000379:methods; D002316:Cardiotonic Agents / Q000627:therapeutic use; D003266:Continuity of Patient Care / Q000458:organization & administration*; D017147:Defibrillators, Implantable; D003688:Deinstitutionalization / Q000379:methods; D004032:Diet; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations; D005081:Exercise Therapy / Q000379:methods; D006333:Heart Failure / Q000534:rehabilitation / Q000628:therapy*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010166:Palliative Care / Q000379:methods; D040242:Risk Reduction Behavior; D055502:Secondary Prevention; D012648:Self Care / Q000379:methods; D016540:Smoking Cessation; D019966:Substance-Related Disorders / Q000517:prevention & control
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics; D004338:Drug Combinations; D000451:Mineralocorticoid Receptor Antagonists; D006830:Hydralazine; D004077:Digoxin; D007548:Isosorbide Dinitrate
keywords: Adjunctive therapy; Heart failure; Management; Transition of care